Latest filing published 06 May 2026 for Novonesis (Novozymes A/S), €132k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Heine Dalsgaard: trading record in brief
All filings by Heine Dalsgaard on record concern Novonesis (Novozymes A/S). Between 30 April 2020 and 6 May 2026, the trades on record add up to 5 filings.
Every open-market trade on record is a purchase: 4 purchases worth €559k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.
Half of the purchases are above €134k and half below. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 6 May 2026 came the latest disclosure, an open-market purchase for €132k in Novonesis (Novozymes A/S). Most trades are made public on the day they happen. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finanstilsynet DK. Past trades are no guide to future returns.
Companies and markets linked to Heine Dalsgaard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ DKK 393.69160.0% of flowShareOMX CopenhagenISIN DK0060336014DK:1440144Canonical exit: 4 Aug 2026 (T+90)
- 2,700 shares@ DKK 371.98020.0% of flowShareOMX CopenhagenISIN DK0060336014DK:1422930
- 2,500 shares@ DKK 397.07160.0% of flowShareNasdaqISIN DK0060336014DK:1402016Canonical exit: 19 Feb 2026 (T+90)
- 3,000 shares@ DKK 398.490.0% of flowShareOMX CopenhagenISIN DK0060336014DK:1384811Canonical exit: 20 Nov 2025 (T+90)
- 3,000 shares@ DKK 333.870.0% of flowShareISIN DK0060336014DK:937832Canonical exit: 29 Jul 2020 (T+90)
5 of 5 declarations